Lynn Morris

29PUBLICATIONS
174CO-AUTHORS
Genetic immunologyInnate immunityNanotoxicology, health and safetyMedical infection agents (incl. prions)Medical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Apr 03, 2026
Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trials.

Carolyn Williamson, Chivonne Moodley, Craig A Magaret

|Jan 19, 2024
Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence features.

Michal Juraska, Hongjun Bai, Allan C deCamp

|Dec 14, 2023
High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials.

Daniel B Reeves, Bryan T Mayer, Allan C deCamp

|Jun 29, 2023
Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials.

Nonhlanhla N Mkhize, Anna E J Yssel, Haajira Kaldine

|Aug 22, 2022
Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition.

Peter B Gilbert, Yunda Huang, Allan C deCamp

Pageof 5